Menstrual Phase Matters When Measuring CRP Levels to Gauge CVD Risk

EGMN -- Careful timing in measuring high-sensitivity C-reactive protein during the menstrual cycle can make all the difference in classifying young women’s risk of cardiovascular disease, new data show.